Latest news
BioCryst Pharmaceuticals (BCRX) Stock Stalls Despite Profit Surge And ORLADEYO Strength - simplywall.stsimplywall.st · Wed, 05 Aug 2026 23:51:15 GMTBioCryst Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 16:50:58 GMTBCRX: Q2 revenue up 45% year-over-year, with robust ORLADEYO growth and strong cash position - TradingViewTradingView · Wed, 05 Aug 2026 14:14:05 GMTBioCryst Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Wed, 05 Aug 2026 14:04:29 GMTBioCryst Reports Second Quarter 2026 Financial Results - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:00:00 GMTBioCryst Starts Shipping ORLADEYO Oral Pellets to Pediatric Patients - Stock TitanStock Titan · Wed, 05 Aug 2026 11:00:00 GMTBioCryst reports Q2 2026 revenue growth and lau... - PluangPluang · Wed, 05 Aug 2026 07:00:00 GMTCSL eyes Andembry spot on paediatric HAE market amid positive Phase III results - Clinical Trials ArenaClinical Trials Arena · Tue, 28 Jul 2026 10:32:49 GMT